Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
Scientific poster · September 4, 2026

Stromal FGF21 Preserves Aged Thymus

Download PDFDownload PNG
Full scientific poster: Stromal FGF21 Preserves Aged Thymus

Full text

Researchers asked whether they could slow age-related shrinkage of the thymus, the organ that makes new T cells, in 24-month-old mice. They raised fibroblast growth factor 21 (FGF21), a metabolic hormone, in liver cells for blood circulation or locally in thymic epithelial cells, the support cells inside the thymus. A fivefold rise in circulating FGF21 left thymus size, cell number and developing T cells unchanged. Local FGF21 preserved the cortex, medulla and their boundary, increased cellularity, and reduced lipid-filled fibroadipogenic cells, stromal cells that accumulate fat. Deleting beta-klotho, the FGF21 co-receptor on thymic epithelial cells, accelerated thymic aging. Where FGF21 was made determined whether the aged thymus retained its T-cell-making structure.

Source article

  1. Youm Y., et al. Enhanced paracrine action of FGF21 in stromal cells delays thymic aging. Nature Aging. 2025. 5(4):576–587. doi:10.1038/s43587-025-00813-5